Wells Fargo & Company MN Sells 13,465 Shares of Encompass Health Co. (NYSE:EHC)

Wells Fargo & Company MN cut its holdings in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 8.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 137,651 shares of the company's stock after selling 13,465 shares during the period. Wells Fargo & Company MN owned about 0.14% of Encompass Health worth $12,712,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of EHC. MassMutual Private Wealth & Trust FSB increased its holdings in Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock worth $27,000 after purchasing an additional 137 shares during the last quarter. CBIZ Investment Advisory Services LLC grew its position in shares of Encompass Health by 38.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock worth $42,000 after buying an additional 127 shares in the last quarter. Tompkins Financial Corp bought a new stake in shares of Encompass Health in the fourth quarter worth $46,000. V Square Quantitative Management LLC raised its holdings in Encompass Health by 43.8% in the fourth quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock valued at $54,000 after acquiring an additional 177 shares in the last quarter. Finally, Signaturefd LLC boosted its stake in Encompass Health by 21.6% during the 4th quarter. Signaturefd LLC now owns 704 shares of the company's stock valued at $65,000 after acquiring an additional 125 shares during the last quarter. 97.25% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Encompass Health

In related news, CAO Andrew L. Price sold 5,042 shares of the business's stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the transaction, the chief accounting officer now directly owns 69,164 shares of the company's stock, valued at approximately $6,798,129.56. The trade was a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 2.10% of the company's stock.

Encompass Health Trading Up 0.5 %

Shares of NYSE EHC traded up $0.53 during mid-day trading on Friday, hitting $103.53. 1,002,397 shares of the company traded hands, compared to its average volume of 666,489. The business has a 50 day moving average of $99.91 and a two-hundred day moving average of $98.29. The stock has a market capitalization of $10.43 billion, a price-to-earnings ratio of 23.21, a PEG ratio of 2.31 and a beta of 0.87. Encompass Health Co. has a 1 year low of $79.26 and a 1 year high of $104.55. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84.

Encompass Health (NYSE:EHC - Get Free Report) last released its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. On average, sell-side analysts anticipate that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st were issued a dividend of $0.17 per share. The ex-dividend date of this dividend was Tuesday, April 1st. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.66%. Encompass Health's dividend payout ratio is 15.25%.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on EHC. Royal Bank of Canada reiterated an "outperform" rating and issued a $110.00 price target on shares of Encompass Health in a report on Tuesday, February 11th. William Blair reissued an "outperform" rating on shares of Encompass Health in a report on Friday, February 7th. StockNews.com lowered shares of Encompass Health from a "buy" rating to a "hold" rating in a report on Wednesday. Barclays increased their price objective on shares of Encompass Health from $116.00 to $118.00 and gave the stock an "overweight" rating in a research note on Friday, February 7th. Finally, KeyCorp lifted their target price on Encompass Health from $117.00 to $120.00 and gave the company an "overweight" rating in a research note on Monday, February 10th. One equities research analyst has rated the stock with a hold rating, nine have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, Encompass Health has an average rating of "Buy" and a consensus target price of $107.67.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.